MGMT and malignant peripheral nerve sheath tumor: Kim et al. examined 62 cases of liposarcoma, leiomyosarcoma, malignant peripheral nerve sheath tumor (MPNST), malignant fibrous histiocytoma (MFH) and synovial sarcoma and reported MGMT promoter methylation in 21/62 cases[13].